Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Globus Medical Completes First Surgery With Excelsius Imaging System

Executive Summary

Globus Medical CFO Keith Pfeil said “enthusiasm is great” with “more than double-digit orders” for the Excelsius3D system.

You may also be interested in...



Execs On The Move, April 2022 Roundup: Shake Ups At Glaukos, Medtronic, BD And Globus

Executives On The Move will be running to a monthly schedule from now, with this edition covering medtech's executive changes for April.

Fracture Fixation Devices Market Projected A Return To Steady Growth

A new Informa Meddevicetracker report outlines projections for the fracture fixation devices market.

Harbinger Health Raised $140M In Series B To Further Develop First Blood-Based Cancer Test

Harbinger Health has raised a total of $190m since its founding in 2021. Its CEO Stephen Hahn told Medtech Insight in March that the company plans to develop a blood-based cancer test that is affordable, accessible and also more accurate than currently available tests.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT145431

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel